Related Experiment Video

Updated: May 6, 2026

The Intra-Aortic Balloon Pump
06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

27.3K

Cardiogenic shock

Howard A Cooper1, Julio A Panza

  • 1Coronary Care Unit, Medstar Heart Institute, Medstar Washington Hospital Center, 110 Irving Street Northwest, Suite NA-1103, Washington, DC 20010, USA.

Cardiology Clinics
|November 6, 2013
PubMed

Insights

Cardiogenic shock (CS) is a life-threatening condition where the heart cannot pump enough blood to meet the body's needs, often caused by heart attack. New treatments are crucial to lower its high death rate.

Area of Science:

  • Cardiology
  • Critical Care Medicine

Background:

  • Cardiogenic shock (CS) is characterized by reduced cardiac output and organ hypoperfusion.
  • Acute myocardial infarction is the most frequent cause of CS.
  • CS involves a detrimental cycle of inflammation, ischemia, and myocardial dysfunction, leading to high mortality.

Purpose of the Study:

  • To highlight the critical nature of cardiogenic shock.
  • To emphasize the need for advanced monitoring and hemodynamic support.
  • To underscore the urgent requirement for novel therapeutic strategies in CS management.

Main Methods:

  • This abstract describes the pathophysiology and clinical implications of CS.
  • It reviews the current standard of care, including intensive monitoring and hemodynamic support.
  • It discusses the limitations of existing treatments and the need for innovation.

Main Results:

  • CS results in inadequate end-organ perfusion and progressive myocardial dysfunction.
  • The condition is associated with an unacceptably high mortality rate.
  • Current therapies, while essential, are insufficient to overcome the disease's complexity.

Conclusions:

  • Cardiogenic shock is a severe medical emergency requiring immediate and aggressive intervention.
  • Effective management necessitates tailored therapies based on specific pathophysiology.
  • Developing innovative treatments is paramount to improving survival rates in CS patients.

Keywords:
Acute myocardial infarctionCardiogenic shockExtracorporeal membrane oxygenationInflammationIntra-aortic balloon pumpLeft ventricular assist devicePrognosisReperfusion

More Related Videos

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

2.8K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.3K

Related Concept Videos

Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.8K
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
569
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
802
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
837
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.7K